Portfolio (Quarterly)
Guide ↗
TANG CAPITAL MANAGEMENT LLC
· CIK 0001232621| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GLPG | GALAPAGOS NV | Healthcare | 3,921,219.0 | $128.2M | 6.33% | -230K | -5.5% | $32.70 | -15.9% |
| 2 | CELC | CELCUITY INC | Healthcare | 1,050,000.0 | $104.7M | 5.17% | -100K | -8.7% | $99.74 | +38.0% |
| 3 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 1,188,624.0 | $97.3M | 4.81% | -1.3M | -51.6% | $81.88 | -20.4% |
| 4 | — | KINIKSA PHARMACEUTICALS INTL | — | 2,259,889.0 | $93.2M | 4.61% | -69K | -3.0% | $41.25 | — |
| 5 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 4,573,530.0 | $73.9M | 3.65% | -468K | -9.3% | $16.15 | +65.7% |
| 6 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 1,892,200.0 | $62.0M | 3.06% | -1.3M | -40.9% | $32.76 | +130.9% |
| 7 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 1,792,626.0 | $55.8M | 2.76% | -1.1M | -36.9% | $31.12 | -45.2% |
| 8 | NUVB | NUVATION BIO INC | Healthcare | 3,857,457.0 | $34.6M | 1.71% | -343K | -8.2% | $8.96 | -47.3% |
| 9 | — | VENTYX BIOSCIENCES INC | — | 2,814,000.0 | $25.4M | 1.25% | -286K | -9.2% | $9.03 | — |
| 10 | NVDA | NVIDIA CORPORATION | Technology | 127,788.0 | $23.8M | 1.18% | -3K | -2.1% | $186.50 | +26.4% |
| 11 | PGEN | PRECIGEN INC | Healthcare | 5,617,500.0 | $23.5M | 1.16% | -6.8M | -54.7% | $4.18 | +10.0% |
| 12 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 500,000.0 | $17.6M | 0.87% | -370K | -42.5% | $35.18 | -9.9% |
| 13 | META | META PLATFORMS INC | Communication Services | 23,331.0 | $15.4M | 0.76% | -3K | -10.3% | $660.09 | -6.3% |
| 14 | GSK | GSK PLC | Healthcare | 300,000.0 | $14.7M | 0.73% | -100K | -25.0% | $49.04 | +3.9% |
| 15 | LENZ | LENZ THERAPEUTICS INC | Healthcare | 865,169.0 | $13.8M | 0.68% | -32K | -3.6% | $16.00 | -54.4% |
| 16 | PCVX | VAXCYTE INC | Healthcare | 275,000.0 | $12.7M | 0.63% | -25K | -8.3% | $46.14 | +16.0% |
| 17 | INSM | INSMED INC | Healthcare | 60,000.0 | $10.4M | 0.52% | -140K | -70.0% | $174.04 | -33.6% |
| 18 | — | DYNAVAX TECHNOLOGIES CORP | — | 556,359.0 | $8.6M | 0.42% | -1.4M | -71.5% | $15.38 | — |
| 19 | EOLS | EVOLUS INC | Healthcare | 1,245,692.0 | $8.3M | 0.41% | -4.2M | -77.3% | $6.65 | -1.1% |
| 20 | URGN | UROGEN PHARMA LTD | Healthcare | 350,000.0 | $8.2M | 0.41% | -650K | -65.0% | $23.42 | +26.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
96.6%
Technology
1.3%
Financial Services
1.1%
Communication Services
0.9%
Real Estate
0.1%